CareStart Covid-19 Antigen Test Kit Using NanoAct Launches in US
Access Bio uses NanoAct in CareStart Covid-19 Ag because its wide range of colors enables better visibility of test lines.
Read MorePosted by Melanie Hamilton-Basich | Dec 8, 2020 | Covid 19 |
Access Bio uses NanoAct in CareStart Covid-19 Ag because its wide range of colors enables better visibility of test lines.
Read MorePosted by Laurie Bonner | Dec 7, 2020 | Covid 19, Infectious Diseases |
The decrease in-person visits during the pandemic led to a 50% decrease in hospital-wide hepatitis C testing and a 60% reduction in new HCV diagnoses, according to research from Boston Medical Center.
Read MorePosted by Laurie Bonner | Dec 7, 2020 | Covid 19, Miscellaneous |
According to the Biden-Harris Transition team, this diverse and experienced slate of nominations and appointments includes some of the nation’s most accomplished problem-solving leaders in crisis management and public health.
Read MorePosted by Melanie Hamilton-Basich | Dec 2, 2020 | Emerging & Zoonotic Diseases |
The guidelines include 43 recommendations related to diagnostic testing, including testing scenarios, detailed recommendations about Lyme carditis, and a discussion of “chronic Lyme disease.”
Read MorePosted by Laurie Bonner | Nov 23, 2020 | Covid 19, Lab Management, Molecular Diagnostics |
Surveys from the Association for Molecular Pathology reveal the impact of the covid-19 pandemic on clinical labs and help to chart the course for 2021.
Read More